Related Articles Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review Synthesis, Characterization and Biological Activity Studies of 1,3,4-Oxadiazole Analogs Drug–drug Interactions in Hospitalized Cardiac Patients Share 0 FacebookTwitterLinkedinEmail Previous Article Next Article